WO2005097960A1 - Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions - Google Patents
Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions Download PDFInfo
- Publication number
- WO2005097960A1 WO2005097960A1 PCT/US2005/011009 US2005011009W WO2005097960A1 WO 2005097960 A1 WO2005097960 A1 WO 2005097960A1 US 2005011009 W US2005011009 W US 2005011009W WO 2005097960 A1 WO2005097960 A1 WO 2005097960A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solution
- component
- ppm
- contact lens
- amount effective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
- A61L12/143—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
- A61L12/143—Quaternary ammonium compounds
- A61L12/145—Polymeric quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/008—Polymeric surface-active agents
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/22—Carbohydrates or derivatives thereof
- C11D3/222—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/26—Organic compounds containing nitrogen
- C11D3/28—Heterocyclic compounds containing nitrogen in the ring
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/34—Organic compounds containing sulfur
- C11D3/349—Organic compounds containing sulfur additionally containing nitrogen atoms, e.g. nitro, nitroso, amino, imino, nitrilo, nitrile groups containing compounds or their derivatives or thio urea
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/34—Organic compounds containing sulfur
- C11D3/3409—Alkyl -, alkenyl -, cycloalkyl - or terpene sulfates or sulfonates
Definitions
- the present invention relates to compositions and methods for eye and contact lens care. More particularly, the invention relates to ophthalmic compositions which contain cetylpyridinium chloride as a decontaminating agent for preservation of the solution and/or disinfecting contact lenses.
- Description of the Prior Art Contact lens wear induces adverse changes in ocular tissues and the tear film. These changes include cornea lactic acidosis and subsequent cornea swelling as a consequence of hypoxia induced by low oxygen gas transmission, changes in corneal epithelial tissue thickness, changes in corneal epithelial and endothelial cell morphology, epithelial surface cell exfoliation, hyperemia (red eye), adverse changes in corneal and conjunctival cell membrane integrity and destabihzation of the tear film.
- CPC cetylpyridinium chloride
- cetylpyridinium chloride (CPC) at low concentrations, in combination with a non-ionic surfactant, can be efficacious as a contact lens disinfection agent.
- the non-ionic surfactant is a poly(oxypropylene)-poly(oxyethylene) block copolymer. Such efficacy may be seen in concentrations ranging from as low as 0.1 ppm or 0.3 ppm to about 8 ppm, 9 ppm or 10 ppm.
- Figure 1 shows the amount of CPC uptake by Purevision® lenses (Bausch & Lomb Incorporated, Rochester New York) as a function of CPC concentration at adsorption equilibrium.
- compositions include, in an aqueous liquid medium, a non-ionic surfactant and cetylpyridinium chloride.
- the non-ionic surfactant is a poly(oxypropylene)-poly(oxyethylene) block copolymer.
- Such solutions may also include one or more of the following: additional antimicrobial components, preferably reduced in concentration from the concentration that is typically used with only one antimicrobial component; a buffer component in an amount effective to maintain the pH of the solution within a physiologically acceptable range; an effective amount of a viscosity inducing component; a surfactant in an amount effective to clean a contact lens contacted with the solution; and a tonicity component in an amount effective to provide the desired tonicity to the solution.
- the solutions may also include taurine. The benefits of including taurine are disclosed in U.S. Patent Application Ser. No. 10/328,641, to S. Huth, entitled “Contact Lens Care Compositions, Methods of Use, and Preparation which Protect Ocular Tissue," which is incorporated herein by reference.
- the solutions of the present invention provide the desired antimicrobial activity and performance effectiveness and, importantly, substantial, preferably enhanced, lens wearer/user comfort and acceptability benefits.
- contact lens cleaning and disinfecting solutions typically contain significant amounts of surfactants in order to clean the contact lens surface which is contaminated mainly by tear protein and lipids.
- surfactants include non-ionic surfactants and non-ionic surfactants.
- non-ionic surfactants are commonly used for contact lens cleaning.
- non-ionic surfactants are also commonly used to neutralize quaternary-based antimicrobial- agents in microbiology test labs. Thus, the concentration must be carefully controlled.
- Anionic surfactants such as soap are generally not compatible with quaternary amine based antimicrobials that are positively charged.
- anionic surfactants would defy the microbial activity of non-polymeric based polyquaternary ammonium compounds. Electrostatic interaction between ion of the surfactant and cation of the quaternary ammonium would neutralize the net charge, eliminate the antimicrobial activity and form a precipitate due to the loss of hydrophilicity by charge neutralization.
- j Cationic surfactants are compatible with alkyl amines, but they themselves are antimicrobial agents, and therefore cannot be added in large amounts without irritating the eye.
- CPC is highly active in specific concentration ranges and can be used in contact lens disinfecting. That is, CPC can be used for contact lens disinfection without significantly building up in a contact lens, provided that it is used with a certain type of surfactant which functions as a cleaning and/or solubilizing agent, and the two are used according to a special mixing ratio.
- a certain type of non-ionic surfactant, used in a certain mixing ratio can reduce CPC lens uptake while maintaining anti-microbial effectiveness for disinfection.
- the present compositions which may be multi-purpose solutions, have a multitude of applications, for example, as disinfecting, cleaning, soaking, wetting, rewetting, rinsing, storing, in-the-eye cleaning, and conditioning compositions, for contact lens care, while providing substantial lens wearer/user comfort and acceptability.
- the present compositions also increase user compliance, that is promote regular and consistent contact lens care, and, ultimately, lead to or facilitate better ocular health.
- Any contact lenses for example, conventional hard contact lenses, rigid gas permeable contact lenses and soft, hydrophilic or hydrogel, contact lenses, including silicone hydrogel contact lenses, can be treated in accordance with the present invention.
- CPC in the presence of a selected non-ionic surfactant, can be efficacious as a contact lens disinfection agent at low concentration ( ⁇ 10 ppm).
- non-ionic surfactants for use in the present invention are disclosed in, for example, Kirk-Othmer, Encyclopedia of Chemical Technology, 3rd Edition, Vol. 22 (John Wiley E Sons, 1983), Sislet & Wood, Encyclopedia of Surface Active Agents (Chemical Publishing Co., Inc. 1964), McCutcheon's Emulsifiers & Detergents, North American and International Edition (McCutcheon Division, The MC Publishing Co., 1991), Ash, The Condensed Encyclopedia of Surfactants (Chemical Publishing Co., Inc., 1989), Ash, What Every Chemical Technologist Wants to Know About . . . Emulsifiers and Wetting Agents, Vol.
- Such surfactants include Tetronic® 1307, Tetronic® 904, Tetronic® 1304, Tetronic® 1107 (BASF Corporation, Mount Olive, New Jersey) and Pluronic® F87 (BASF Corporation, Mount Olive, New Jersey).
- the additional antimicrobial component may be any suitable, preferably ophthalmically acceptable, material effective to disinfect a contact lens contacted with the present solutions or alternatively adequately preserve a solution such as a contact lens rewetting solution.
- the additional antimicrobial component is selected from biguanides, biguanide polymers, salts thereof and mixtures thereof, and is present in an amount in the range of about 0.1 ppm to about 3 ppm or less than 5 ppm (w/v).
- the additional antimicrobial component may be a monomeric quaternary ammonium or biguanide compound such as chlorhexidine digluconate, chlorhexidine diacetate, benzethonium chloride and myristamidopropyldimethylamine.
- the additional antimicrobial component may also be a polymeric quaternary ammonium compound such as Polyquad.RTM. (polyquatemium-1) or poly [oxyethylene (dimethyliminio) ethylene-(dimethyliminio) ethylene dichloride] (sold under the trademark WSCP by Buckman Laboratories, Inc.).
- the preferred relatively reduced concentration of the additional antimicrobial component has been found to be very effective, in the present compositions, in disinfecting contact lenses contacted with the compositions, while at the same time promoting lens wearer/user comfort and acceptability.
- any suitable, preferably ophthalmically acceptable viscosity inducing or thickening agent may be included in the present compositions.
- the viscosity inducing component preferably is selected from cellulosic derivatives and mixtures thereof and is present in an amount in the range of about 0.05% or about 1.5% to about 3% or about 5.0% (w/v).
- a viscosity inducing component at least assists in providing the lens wearer/user comfort and acceptability benefits of the present invention, which promote regular and consistent contact lens care and ultimately lead to or facilitate better ocular health.
- the present combinations of components for example, including such viscosity inducing components, are effective in providing the degree of lens wearer/user comfort and acceptability benefits described herein.
- an extremely useful tonicity component is a combination of sodium chloride and potassium chloride.
- the present compositions preferably include an effective amount of a chelating component.
- a chelating component Any suitable, preferably ophthalmically acceptable, chelating component may be included in the present compositions, although ethylenediaminetetraacetic acid (EDTA), salts thereof and mixtures thereof are particularly effective.
- the present compositions include chelating components in effective amounts less than about 0.05% (w/v) and still more preferably 0.02°s (w/v) or less. Such reduced amounts of chelating component in the present compositions remain effective in providing the desired chelating and/or sequestering functions while, at the same time, are better tolerated in the eye, thereby reducing the risk of user discomfort and/or ocular irritation.
- each of the components, in the concentration employed, included in the solutions and the formulated solutions of the present invention generally are ophthalmically acceptable.
- each of the components (in the case of the CPC, in combination with the non-ionic surfactant as described above), in the concentration employed included in the present solutions usually is soluble in the liquid aqueous medium.
- the solution may also optionally include an additional antimicrobial component in an amount effective to, in association with the remainder of the solution, disinfect a contact lens contacted with the composition.
- a solution or component thereof is "ophthalmically acceptable" when it is compatible with ocular tissue, that is, it does not cause significant or undue detrimental effects when brought into contact with ocular tissue.
- each component of the present compositions is also compatible with the other components of the present compositions.
- the present compositions are more preferably substantially ophthalmically optimized.
- An ophthalmically optimized composition is one which, within the constraints of component chemistry, minimizes ocular response, or conversely delivers ophthalmic benefit to the lens wearing eye.
- the presently useful additional antimicrobial components include chemicals which derive their antimicrobial activity through a chemical or physiochemical interaction with microbes or microorganisms, such as those contaminating a contact lens.
- Suitable additional antimicrobial components are those generally employed in ophthalmic applications and include, but are not limited to, quaternary ammonium salts used in ophthalmic applications such as poly [dimethylimino-2-butene-l, 4-diyl] chloride, alpha - [4-tris (2-hydroxyethyl) ammonium] -dichloride (chemical registry number 75345-27-6, available under, the trademark Polyquateraium 1® from Onyx Corporation), benzalkonium halides, and biguanides, such as salts of alexidine, alexidine-free base, salts of chlorhexidine, hexamethylene biguanides and their polymers, and salts thereof, antimicrobial polypeptides, chlorine dioxide precursors, and the like and mixtures thereof
- PHMB hexamethylene biguanide polymers
- PAPB polyaminopropyl biguanide
- the antimicrobial component is present in the liquid aqueous medium at an ophthalmically acceptable or safe concentration such that the user can remove the disinfected lens from the liquid aqueous medium and thereafter directly place the lens in the eye for safe and comfortable wear.
- the antimicrobial component is present in the liquid aqueous medium at an ophthalmically acceptable or safe concentration and sufficient for maintaining preservative effectiveness.
- the additional antimicrobial components suitable for inclusion in the present invention include chlorine dioxide precursors.
- chlorine dioxide precursors include stabilized chlorine dioxide (SCD), metal chlorites, such as alkali metal and alkaline earth metal chlorites, and the like and mixtures thereof.
- Technical grade sodium chlorite is a very useful chlorine dioxide precursor.
- Chlorine dioxide containing complexes such as complexes of chlorine dioxide with carbonate, chlorine dioxide with bicarbonate and- mixtures thereof are also included as chlorine dioxide precursors.
- the exact chemical composition of many chlorine dioxide precursors, for example, SCD and the chlorine dioxide complexes, is not completely understood.
- the manufacture or production of certain chlorine dioxide precursors is described in McNicholas, U.S. Patent 3,278,447, which is incorporated in its entirety herein by reference.
- Specific examples of useful SCD products include that sold under the tiademark Dura Klor® by Rio Linda Chemical Company, Inc., and that sold under the trademark Anthium Dioxide® by International Dioxide, Inc.
- a chlorine dioxide precursor in included in the present compositions it generally is present in an effective preservative or contact lens disinfecting amount.
- Such effective preservative or disinfecting concentrations usually are in the range of about 0.002 to about 0.06% (w/v) of the present compositions.
- the chlorine dioxide precursors may be used in combination with other antimicrobial components, such as biguanides, biguanide polymers, salts thereof and mixtures thereof.
- the compositions usually have an osmolality of at least about 200 mOsmol/kg and are buffered to maintain the pH within an acceptable physiological range, for example, a range of about 6 to about 10.
- compositions usually further comprise effective amounts of one or more additional components, such as a detergent or surfactant component; a viscosity inducing or thickening component; a chelating or sequestering component; a tonicity component; and the like and mixtures thereof.
- additional component or components may be selected from • materials which are known to be useful in contact lens care compositions and are included in amounts effective to provide the desired effect or benefit.
- an additional component is included, it is generally compatible under typical use and storage conditions with the other components of the composition.
- the aforesaid additional component or components are substantially stable in the presence of the antimicrobial and buffer components described herein.
- the viscosity inducing components employed in the present solutions preferably are effective at low or reduced concentrations, compatible with the other components of the present solutions, and anionic and non-ionic. Such viscosity inducing components are effective to enhance and/or prolong the cleaning and wetting activity of the surfactant component and/or condition the lens surface rendering it more hydrophilic (less lipophilic) and/or to act as a demulcent on the eye. Increasing the solution viscosity provides a film on the lens which may facilitate comfortable wearing of the treated contact lens. The viscosity inducing component may also act to cushion the impact on the eye surface during insertion and serves also to alleviate eye irritation.
- Suitable viscosity inducing components include, but are not limited to, water soluble natural gums, cellulose-derived polymers and the like.
- Useful natural gums include guar gum, gum tragacanth and the like.
- Useful cellulose-derived viscosity inducing components include cellulose-derived polymers, such as hydroxypropyl cellulose, hydroxypropylmethyl cellulose, carboxymethyl cellulose, methyl cellulose, hydroxyethyl cellulose and the like. More preferably, the viscosity inducing agent is selected from cellulose derivatives (polymers) and mixtures thereof.
- a very useful viscosity inducing component is hydroxypropylmethyl cellulose (HPMC).
- a reduced amount is employed, for example, in the range of less than about 0.05% (w/v) or even about 0.02% (w/v) or less.
- Such reduced amounts of chelating component have been found to be effective in the present compositions while, at the same time, providing for reduced cytotoxicity, discomfort and/or ocular irritation.
- the liquid aqueous medium preferably includes an effective amount of a tonicity component to provide the liquid medium with the desired tonicity.
- a tonicity component may be present in the liquid aqueous medium and/or may be introduced into the liquid aqueous medium.
- suitable tonicity adjusting components that may be employed are those conventionally used in contact lens care products, such as various inorganic salts.
- Sodium chloride and/or potassium chloride and the like are very useful tonicity components.
- the amount of tonicity component included is effective to provide the desired degree of tonicity to the solution. Such amount may, for example, be in the range of about 0.1% to about 1.5% (w/v). If a combination of sodium chloride and potassium chloride is employed, it is preferred that the weight ratio of sodium chloride to potassium chloride be in the range of about 2.5 to about 6 or about 8.
- Candida albicans ATCC 10231, is one of five organisms specified per FDA and ISO/CLI tests for the testing of contact lens disinfectants (FDA Premarket Notification (510k) Guidance Document for Contact Lens Care Products, Appendix A and B, May 1, 1997 and ISO/FDIS 14729: Ophthalmic optics-Contact lens care products- Microbiological requirements and test methods for products and regimens for hygienic management of contact lenses, January 2001).
- Contact lens disinfectants are also known as contact lens multipurpose solutions when they are used for rinsing, cleaning, disinfection, storage and rewetting contact lenses.
- the five FDA/ISO specified test organisms are listed below:
- Candida albicans is often the most resistant of the five organisms to commonly used cationic antimicrobial agents in contact lens multi-purpose solutions. Thus, achievement of adequate antimicrobial activity against Candida is often the most difficult task to pass a particular disinfection efficacy standard.
- FDA and ISO guidelines specify two disinfection efficacy standards, indicated in the table below: Stand Alone Disinfectant (Primary) Criteria: Organism Average log reduction at labeled soak time S. marcescens 3.0 logs S. aureus 3.0 logs P. aeruginosa 3.0 logs C. albicans 1.0 log F. solani 1.0 log
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE602005013498T DE602005013498D1 (en) | 2004-04-07 | 2005-03-31 | Cetylpyridinechloride as Antimicrobial Agent in Ophalmic Compositions |
CA2562546A CA2562546C (en) | 2004-04-07 | 2005-03-31 | Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions |
AU2005230851A AU2005230851B2 (en) | 2004-04-07 | 2005-03-31 | Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions |
BRPI0509654-5A BRPI0509654A (en) | 2004-04-07 | 2005-03-31 | cetylpyridinium chloride as antimicrobial agent in ophthalmic compositions |
JP2007507379A JP2007532953A (en) | 2004-04-07 | 2005-03-31 | Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions |
CN200580011933XA CN1942571B (en) | 2004-04-07 | 2005-03-31 | Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions |
EP05763160A EP1733014B1 (en) | 2004-04-07 | 2005-03-31 | Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/820,486 | 2004-04-07 | ||
US10/820,486 US7578996B2 (en) | 2004-04-07 | 2004-04-07 | Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005097960A1 true WO2005097960A1 (en) | 2005-10-20 |
Family
ID=34972927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/011009 WO2005097960A1 (en) | 2004-04-07 | 2005-03-31 | Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions |
Country Status (11)
Country | Link |
---|---|
US (2) | US7578996B2 (en) |
EP (1) | EP1733014B1 (en) |
JP (1) | JP2007532953A (en) |
CN (1) | CN1942571B (en) |
AT (1) | ATE426655T1 (en) |
AU (1) | AU2005230851B2 (en) |
BR (1) | BRPI0509654A (en) |
CA (1) | CA2562546C (en) |
DE (1) | DE602005013498D1 (en) |
ES (2) | ES2321214T3 (en) |
WO (1) | WO2005097960A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007075556A2 (en) * | 2005-12-20 | 2007-07-05 | Johnson & Johnson Vision Care, Inc. | Method for removing unreacted components from hydrogel ophthalmic lenses |
WO2012080918A2 (en) * | 2010-12-14 | 2012-06-21 | Ecolab Usa Inc. | Wear resistant antimicrobial compositions and methods of use |
WO2018109456A1 (en) * | 2016-12-12 | 2018-06-21 | Provita Eurotech Ltd | Antimicrobial compositions |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070264226A1 (en) * | 2006-05-10 | 2007-11-15 | Karagoezian Hampar L | Synergistically enhanced disinfecting solutions |
US8759321B2 (en) * | 2007-06-13 | 2014-06-24 | Bausch & Lomb Incorporated | Ophthalmic composition with hyaluronic acid and polymeric biguanide |
TWI419719B (en) * | 2007-08-31 | 2013-12-21 | Novartis Ag | Contact lens products |
US9096819B2 (en) | 2008-01-31 | 2015-08-04 | Bausch & Lomb Incorporated | Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer |
US8119112B2 (en) * | 2008-01-31 | 2012-02-21 | Bausch & Lomb Incorporated | Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid |
US20110046033A1 (en) | 2008-01-31 | 2011-02-24 | Jinzhong Zhang | Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function |
US20100286010A1 (en) * | 2008-09-03 | 2010-11-11 | Erning Xia | Ophthalmic Compositions with Hyaluronic Acid |
US9125405B2 (en) * | 2008-10-28 | 2015-09-08 | Bausch & Lomb Incorporated | Contact lens solution with a tertiary amine oxide |
BR112014008255B1 (en) | 2011-10-08 | 2020-12-15 | Next Science IP Holdings Pty Ltd | ANTIMICROBIAL COMPOSITIONS AND METHODS USING THE SAME |
CN104202973A (en) * | 2011-11-06 | 2014-12-10 | Nbip有限责任公司 | Anti-microbial compositions and related methods |
CN102552914A (en) * | 2012-01-31 | 2012-07-11 | 江西科伦药业有限公司 | Composition capable of simultaneously adjusting pH value and osmotic pressure and preparation method thereof |
US8664180B2 (en) | 2012-02-06 | 2014-03-04 | Bausch & Lomb Incorporated | Ophthalmic compositions containing diglycine |
US8324171B1 (en) | 2012-02-06 | 2012-12-04 | Bausch & Lomb Incorporated | Ophthalmic compositions containing diglycine |
CN102835398A (en) * | 2012-09-28 | 2012-12-26 | 山东潍坊润丰化工有限公司 | Method for preparing clopyralid choline aqueous solution and active compound |
MX2016012457A (en) * | 2014-03-24 | 2017-02-28 | Johnson & Son Inc S C | Corrosive ingredient (s) - containing compositions having reduced toxicity and method of obtaining. |
TW202014194A (en) * | 2018-04-27 | 2020-04-16 | 美商歐樂根公司 | Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity |
JP7253128B2 (en) * | 2018-06-13 | 2023-04-06 | 京都バイオファーマ製薬株式会社 | External composition containing depsipeptide antibiotic |
CN112312791B (en) | 2018-06-27 | 2023-05-26 | 鲍希与洛姆伯股份有限公司 | Packaging solution |
US11752175B2 (en) * | 2018-09-21 | 2023-09-12 | Cornell University | Compositions and methods for glaucoma |
AU2020395914A1 (en) * | 2019-12-05 | 2022-05-19 | Cis Pharma Ag | High hyaluronate multi-purpose disinfection solutions for ophthalmic applications |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4043911A (en) * | 1975-03-24 | 1977-08-23 | Baylor College Of Medicine | Sterilization of holding tanks and toilet bowls by quaternary compounds |
WO1992016244A1 (en) * | 1991-03-18 | 1992-10-01 | Allergan, Inc. | Contact lens disinfecting compositions |
US5252246A (en) * | 1992-01-10 | 1993-10-12 | Allergan, Inc. | Nonirritating nonionic surfactant compositions |
WO1994027436A1 (en) * | 1993-05-20 | 1994-12-08 | Decicco Benedict T | Preservative systems with enhanced antimicrobial activity |
EP1149531A1 (en) * | 2000-04-25 | 2001-10-31 | Wako Pure Chemical Industries, Ltd. | Anti-protista preparation |
KR20020041118A (en) * | 2000-11-27 | 2002-06-01 | 김용철 박홍양 | Treating and Prophylactic Preparation for Poultry Newcastle Disease |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3278447A (en) * | 1963-12-02 | 1966-10-11 | Cloro Bac Products Inc | Process for stabilizing chlorine dioxide solution |
USB724600I5 (en) * | 1968-04-26 | |||
AR207548A1 (en) * | 1972-08-11 | 1976-10-15 | Flow Pharma Inc | AQUEOUS COMPOSITION TO CLEAN AND TREAT CONTACT LENSES |
US4758595A (en) * | 1984-12-11 | 1988-07-19 | Bausch & Lomb Incorporated | Disinfecting and preserving systems and methods of use |
US4908147A (en) * | 1986-02-19 | 1990-03-13 | Ciba-Geigy Corporation | Aqueous self preserving soft contact lens solution and method |
US5110493A (en) * | 1987-09-11 | 1992-05-05 | Syntex (U.S.A.) Inc. | Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant |
JP3297969B2 (en) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | Eye drops |
EP0855187A3 (en) * | 1997-01-24 | 2001-01-17 | Senju Pharmaceutical Co., Ltd. | Agent for contact lenses |
US20030228393A1 (en) * | 2002-05-31 | 2003-12-11 | Zhao Iris Ginron | Multi-phase food & beverage |
US6020375A (en) * | 1997-06-13 | 2000-02-01 | Senju Pharmaceutical Co., Ltd. | Bactericidal composition |
US6482799B1 (en) * | 1999-05-25 | 2002-11-19 | The Regents Of The University Of California | Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial |
JP3677421B2 (en) * | 1999-12-27 | 2005-08-03 | 扶桑薬品工業株式会社 | Composition for promoting lacrimal secretion |
TW200300448A (en) * | 2001-11-21 | 2003-06-01 | Novartis Ag | Conditioning solution for contact lenses |
AU2002359635A1 (en) * | 2001-12-05 | 2003-06-17 | Mitokor, Inc. | Use of polycyclic phenolic compounds for the treatment of opthalmic diseases |
US20040120916A1 (en) * | 2002-12-23 | 2004-06-24 | Advanced Medical Optics, Inc. | Contact lens care compositions, methods of use and preparation which protect ocular tissue membrane integrity |
-
2004
- 2004-04-07 US US10/820,486 patent/US7578996B2/en active Active
-
2005
- 2005-03-31 CA CA2562546A patent/CA2562546C/en not_active Expired - Fee Related
- 2005-03-31 ES ES05763160T patent/ES2321214T3/en active Active
- 2005-03-31 DE DE602005013498T patent/DE602005013498D1/en active Active
- 2005-03-31 ES ES200650070A patent/ES2323827B1/en not_active Expired - Fee Related
- 2005-03-31 EP EP05763160A patent/EP1733014B1/en not_active Not-in-force
- 2005-03-31 CN CN200580011933XA patent/CN1942571B/en not_active Expired - Fee Related
- 2005-03-31 AT AT05763160T patent/ATE426655T1/en not_active IP Right Cessation
- 2005-03-31 JP JP2007507379A patent/JP2007532953A/en active Pending
- 2005-03-31 BR BRPI0509654-5A patent/BRPI0509654A/en not_active Application Discontinuation
- 2005-03-31 AU AU2005230851A patent/AU2005230851B2/en not_active Ceased
- 2005-03-31 WO PCT/US2005/011009 patent/WO2005097960A1/en active IP Right Grant
-
2009
- 2009-05-21 US US12/470,375 patent/US20090318512A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4043911A (en) * | 1975-03-24 | 1977-08-23 | Baylor College Of Medicine | Sterilization of holding tanks and toilet bowls by quaternary compounds |
WO1992016244A1 (en) * | 1991-03-18 | 1992-10-01 | Allergan, Inc. | Contact lens disinfecting compositions |
US5252246A (en) * | 1992-01-10 | 1993-10-12 | Allergan, Inc. | Nonirritating nonionic surfactant compositions |
WO1994027436A1 (en) * | 1993-05-20 | 1994-12-08 | Decicco Benedict T | Preservative systems with enhanced antimicrobial activity |
EP1149531A1 (en) * | 2000-04-25 | 2001-10-31 | Wako Pure Chemical Industries, Ltd. | Anti-protista preparation |
KR20020041118A (en) * | 2000-11-27 | 2002-06-01 | 김용철 박홍양 | Treating and Prophylactic Preparation for Poultry Newcastle Disease |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Section Ch Week 200301, Derwent World Patents Index; Class B03, AN 2003-010728, XP002344287 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007075556A2 (en) * | 2005-12-20 | 2007-07-05 | Johnson & Johnson Vision Care, Inc. | Method for removing unreacted components from hydrogel ophthalmic lenses |
WO2007075556A3 (en) * | 2005-12-20 | 2007-09-07 | Johnson & Johnson Vision Care | Method for removing unreacted components from hydrogel ophthalmic lenses |
US7776238B2 (en) | 2005-12-20 | 2010-08-17 | Vanderlaan Douglas G | Methods and systems for leaching silicone hydrogel ophthalmic lenses |
WO2012080918A2 (en) * | 2010-12-14 | 2012-06-21 | Ecolab Usa Inc. | Wear resistant antimicrobial compositions and methods of use |
WO2012080918A3 (en) * | 2010-12-14 | 2012-11-22 | Ecolab Usa Inc. | Wear resistant antimicrobial compositions and methods of use |
US10912299B2 (en) | 2010-12-14 | 2021-02-09 | Ecolab Usa Inc. | Wear resistant antimicrobial compositions and methods of use |
WO2018109456A1 (en) * | 2016-12-12 | 2018-06-21 | Provita Eurotech Ltd | Antimicrobial compositions |
Also Published As
Publication number | Publication date |
---|---|
ES2323827A1 (en) | 2009-07-24 |
AU2005230851A1 (en) | 2005-10-20 |
JP2007532953A (en) | 2007-11-15 |
US20050226841A1 (en) | 2005-10-13 |
EP1733014B1 (en) | 2009-03-25 |
DE602005013498D1 (en) | 2009-05-07 |
ES2321214T3 (en) | 2009-06-03 |
CN1942571B (en) | 2012-02-15 |
EP1733014A1 (en) | 2006-12-20 |
US7578996B2 (en) | 2009-08-25 |
ES2323827B1 (en) | 2010-04-19 |
CN1942571A (en) | 2007-04-04 |
BRPI0509654A (en) | 2007-10-09 |
US20090318512A1 (en) | 2009-12-24 |
ATE426655T1 (en) | 2009-04-15 |
CA2562546A1 (en) | 2005-10-20 |
CA2562546C (en) | 2013-11-19 |
AU2005230851B2 (en) | 2010-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005230851B2 (en) | Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions | |
US7488706B2 (en) | Alkylamine as an antimicrobial agent in ophthalmic compositions | |
AU653768B2 (en) | Method and composition for disinfecting contact lenses | |
AU745778B2 (en) | Multi-purpose contact lens care compositions | |
EP1140224B1 (en) | Contact lens cleaner comprising biguanide, tyloxapol and poloxamine | |
US20070059332A1 (en) | Multi purpose contact lens care compositions including propylene glycol or glycerin | |
US6309596B1 (en) | Treatment of contact lenses with aqueous solution comprising a biguanide disinfectant stabilized by a poloxamine | |
EP1871432A2 (en) | Borate-polyol mixtures as a buffering system | |
EP2430139A1 (en) | Ophthalmic compositions with biguanide and peg-glycerol esters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005763160 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 200650070 Country of ref document: ES Kind code of ref document: A Ref document number: 200650069 Country of ref document: ES Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: P200650070 Country of ref document: ES Ref document number: P200650069 Country of ref document: ES Ref document number: 2562546 Country of ref document: CA Ref document number: 2005230851 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580011933.X Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007507379 Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
ENP | Entry into the national phase |
Ref document number: 2005230851 Country of ref document: AU Date of ref document: 20050331 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005230851 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005763160 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0509654 Country of ref document: BR |
|
WWP | Wipo information: published in national office |
Ref document number: 200650069 Country of ref document: ES Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 200650070 Country of ref document: ES Kind code of ref document: A |
|
WWG | Wipo information: grant in national office |
Ref document number: 200650069 Country of ref document: ES Kind code of ref document: A |
|
WWG | Wipo information: grant in national office |
Ref document number: 200650070 Country of ref document: ES Kind code of ref document: A |